1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow GenSci004: new trials by email Literature Review of GenSci004 trials Research Report on GenSci004
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency GenSci004, Genotropin - GHD | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 162 | 2023-12-01 | 2023-09-11 |
Changchun GeneScience Pharmaceutical Co., Ltd. (1)
United States (1)
Bradley Miller (1)